HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

506.075

-10.940-2.12%

Number of Gainers:9

Number of Losers:21

Number of Flat:3

PE:- -

High:516.490

Open:516.490

Low:500.597

Close:517.015

Volume:149.97M

Turnover:4.87B

Market Cap:324.25B

Float Cap:288.12B

Loading ...

CLSA Says CansinoBio Shares Surge as Moderna's mRNA Cancer Vaccine Succeeds in Late-Stage Trial

HBM Holdings Surges Nearly 15% as China Approves Clinical Trial Application for Late-Stage Solid Tumor Therapy

Historic mRNA Cancer Vaccine Breakthrough Sends Pharmaceutical Stocks Soaring on US, A-share, and HK Markets

KEYMED BIO-B Surges Over 6% Pre-Market as H1 Drug Sales Climb 132%

Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release

Record Earnings From Industry Leaders Signal Peak Season for Innovative Drug Mid-Year Reports?

EVEREST MED Surges Over 89% at Market Open on Strong First-Half Revenue of 1.148 Billion Yuan, Up 157% Year-on-Year

Market Opens Higher Across All Three Major Indices, Led by Precious Metals and Pharmaceuticals

Everest Medicines Surges 15% as Moderna's Cancer Vaccine Breakthrough Revitalizes mRNA Sector

Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost

Ascentage Pharma Posts Interim Results Presentation on 1H 2026 Business Update

US Treasury Steps In to Calm Markets, Ending Wall Street's Three-Day Slide, While Moderna's Cancer Vaccine Breakthrough Sends Shares Soaring 176%

GENFLEET-B Advances Two First-in-Class Pancreatic Cancer Combination Therapies into Phase II Trials

Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion

Ascentage Pharma Group International Posts H1 Net Loss Attributable Rmb816.7 Million

China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up

Ascentage Pharma Group International H1 Revenue RMB 302.2 Million

THOMSON REUTERS

Ascentage Pharma FY26 H1 Loss Widens to Us$120.4 Million; Revenue Rises 29% to Us$44.5 Million

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

THOMSON REUTERS

Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1574/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":506.0749,"timestamp":1787299686774,"preClose":517.0147,"halted":0,"volume":149966252,"delay":0,"changeRate":-0.02116,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-10.939819,"latestTime":"08-21 16:00:00","open":516.49023,"high":516.49023,"low":500.59692,"amount":4865243342.5,"amplitude":0.030741,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"pbRate":4.109535,"peRate":-81.157718,"turnoverRate":0.005372,"increases":11,"decrements":20,"flats":2,"marketCap":324245256080,"floatMarketCap":288118014384},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":516.49023,"amplitude":0.030741,"preClose":517.0147,"low":500.59692,"pbRate":"4.109535","latestPrice":506.0749,"volume":149966252,"delay":0,"open":516.49023,"prevYearClose":556.26263,"prevWeekClose":518.327,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":518.327,"twentyDayClose":498.407,"sixtyDayClose":542.586,"secType":"PLATE","market":"HK","turnoverRate":0.005372,"peRate":-81.157718,"marketCap":324245256080,"floatMarketCap":288118014384,"timestamp":1787299686774,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":9,"down":21,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141282222","title":"CLSA Says CansinoBio Shares Surge as Moderna's mRNA Cancer Vaccine Succeeds in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1141282222","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141282222?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:42","pubTimestamp":1787211738,"startTime":"0","endTime":"0","summary":"Shares of CansinoBio (06185) jumped more than 50% in half a day of trading, driven by positive results from Moderna's (MRNA.US) Phase 3 clinical trial for its mRNA cancer vaccine, according to a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185","BK1515","BK1574","BK1161","BK1191","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129435717","title":"HBM Holdings Surges Nearly 15% as China Approves Clinical Trial Application for Late-Stage Solid Tumor Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1129435717","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129435717?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:14","pubTimestamp":1787210052,"startTime":"0","endTime":"0","summary":"Shares of HBM Holdings-B (02142) climbed nearly 15% in Hong Kong trading on Monday, with the stock last up 11.73% at HK$16.19, on turnover of HK$278 million.The surge follows the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK4588","KCAI","VXUS","BK1574","BK1583","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102476446","title":"Historic mRNA Cancer Vaccine Breakthrough Sends Pharmaceutical Stocks Soaring on US, A-share, and HK Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1102476446","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102476446?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:10","pubTimestamp":1787206241,"startTime":"0","endTime":"0","summary":"A landmark event has shaken the pharmaceutical world. Moderna and Merck announced that their jointly developed personalized mRNA cancer vaccine, Intismeran (V940), successfully met both the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159938","520880","BK1574","09939","159646","01477","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136749730","title":"KEYMED BIO-B Surges Over 6% Pre-Market as H1 Drug Sales Climb 132%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136749730","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136749730?lang=en_us&edition=fundamental","pubTime":"2026-08-20 11:50","pubTimestamp":1787197821,"startTime":"0","endTime":"0","summary":"Shares of KEYMED BIO-B (02162) climbed more than 7% during intraday trading, with the stock last up 6.42% at HK$82, on a turnover of HK$103 million.The company announced on August 19, 2026 that its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02162","BK1161","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102229692","title":"Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1102229692","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102229692?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:36","pubTimestamp":1787193374,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (02096) jumped more than 5% in early trading on Wednesday, with shares last up 4.27% at HK$12.69, recording a turnover of HK$40.17 million. The stock's upward momentum comes as...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BD","02096","BK4588","159992","IBBQ","BK1191","KCAI","BK1583","MEDX","LNGR","VXUS","BK1574","BK1161","BK4585","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192579782","title":"Record Earnings From Industry Leaders Signal Peak Season for Innovative Drug Mid-Year Reports?","url":"https://stock-news.laohu8.com/highlight/detail?id=1192579782","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192579782?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:30","pubTimestamp":1787193031,"startTime":"0","endTime":"0","summary":"Strong financial results from sector frontrunners are fueling market optimism, with many innovative drug companies poised to deliver their most impressive interim reports yet.A bullish technical...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1574","MEDX","IBBQ","BK1161","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190824654","title":"EVEREST MED Surges Over 89% at Market Open on Strong First-Half Revenue of 1.148 Billion Yuan, Up 157% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1190824654","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190824654?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:50","pubTimestamp":1787190624,"startTime":"0","endTime":"0","summary":"EVEREST MED (01952) soared as much as 89% in early trading on the Hong Kong Stock Exchange, with shares last up 54.62% at HK$36.80, on turnover of HK$759 million.The innovative drugmaker EVEREST MED...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1161","01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178179537","title":"Market Opens Higher Across All Three Major Indices, Led by Precious Metals and Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1178179537","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178179537?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:46","pubTimestamp":1787190382,"startTime":"0","endTime":"0","summary":"Trading data shows that on August 20, the Shanghai Composite Index opened up 0.33% at 3907.21 points, the Shenzhen Component Index opened up 1.03% at 14032.97 points, the ChiNext Index opened up...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","02827","DBP","83130","BK1161","BK1515","399300","YSAG","09939","BK1574","BK1147","83188","07233","03130","03188","02846","159938","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192970891","title":"Everest Medicines Surges 15% as Moderna's Cancer Vaccine Breakthrough Revitalizes mRNA Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1192970891","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192970891?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:34","pubTimestamp":1787189670,"startTime":"0","endTime":"0","summary":"EVEREST MED (01952) opened nearly 15% higher on Tuesday, with shares climbing 14.96% to HK$27.36 at the time of writing, recording a turnover of HK$12.26 million.The surge comes after Moderna and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1574","KCAI","BK1583","BK1161","VXUS","159646","01952","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129240025","title":"Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=1129240025","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129240025?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:34","pubTimestamp":1787189660,"startTime":"0","endTime":"0","summary":"CansinoBio (06185) opened 15% higher in Hong Kong trading, with shares last up 15% at HK$26.84, recording a turnover of HK$3.88 million. The surge comes after Moderna and Merck announced on the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","VXUS","06185","BK4585","KCAI","BK1574","BK4588","159646","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660753474","title":"Ascentage Pharma Posts Interim Results Presentation on 1H 2026 Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2660753474","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660753474?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:16","pubTimestamp":1787188598,"startTime":"0","endTime":"0","summary":"Ascentage Pharma posts interim results presentation on 1H 2026 business updateAscentage reported 1H 2026 revenue of USD 44.5 million, up 29% year over year; product sales totaled USD 41.6 million.Cash","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL44PrT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146381026","title":"US Treasury Steps In to Calm Markets, Ending Wall Street's Three-Day Slide, While Moderna's Cancer Vaccine Breakthrough Sends Shares Soaring 176%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146381026","media":"Stock News","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146381026?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:10","pubTimestamp":1787188237,"startTime":"0","endTime":"0","summary":"Market Open Briefing1. US Treasury intervention steadies markets; Moderna surges 176%US stocks snapped a three-session losing streak after the Treasury Department moved to address bond market...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK1161","07233","159982","83130","BK1515","BK4534","BK4585","09939","BK4139","BK1574","83188","BK4532","WDNA","BK4533","02827","BK4588","399300","BK4551","BK1147","GNOM","03130","03188","MRNX","MRNA","MRNY","BK4568","IDNA","LGHT","BK4501","02846","159938","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193023804","title":"GENFLEET-B Advances Two First-in-Class Pancreatic Cancer Combination Therapies into Phase II Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1193023804","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193023804?lang=en_us&edition=fundamental","pubTime":"2026-08-20 08:16","pubTimestamp":1787184978,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has announced the initiation of a three-arm, parallel-controlled Phase II clinical study evaluating GFH375, an oral KRAS G12D ON/OFF inhibitor. The trial will assess two novel...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161","BK1515","09939","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199487193","title":"Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1199487193","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199487193?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:40","pubTimestamp":1787182818,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) has announced its interim results for the first half of 2026, showcasing continued momentum in its commercial operations. Total revenue for the period...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4139","BK1574","06855","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660116479","title":"Ascentage Pharma Group International Posts H1 Net Loss Attributable Rmb816.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660116479","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660116479?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:29","pubTimestamp":1787182190,"startTime":"0","endTime":"0","summary":"BRIEF-Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 MillionAug 20 (Reuters) - Ascentage Pharma Group International H1 revenue RMB 302.2 millionH1 net income attributable RMB -816.7 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXJC7R3Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","06855"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479671","title":"China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479671","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479671?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:17","pubTimestamp":1787181459,"startTime":"0","endTime":"0","summary":"China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-upOverviewChina oncology drug developer's H1 revenue rose 29% yr/yr on higher product salesNet loss widened as operating expenses and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G15G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","IE00BZ08YR35.GBP","BK1574","06990","06855","LU2148510915.USD","IE00BZ08YT58.USD","LU1979443071.USD","BK1589","LU1064131003.USD","BK1521","BK1191","LU1934453819.USD","01177","BK0060","LU1064130708.USD","BK1515","BK0239","002422","HK0000165453.HKD","BK1161","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479392","title":"Ascentage Pharma Group International H1 Revenue RMB 302.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479392?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:00","pubTimestamp":1787180455,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXJC7R3Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","06855"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660313479","title":"Ascentage Pharma FY26 H1 Loss Widens to Us$120.4 Million; Revenue Rises 29% to Us$44.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660313479","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660313479?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:00","pubTimestamp":1787180428,"startTime":"0","endTime":"0","summary":"Ascentage Pharma FY26 H1 loss widens to US$120.4 million; revenue rises 29% to US$44.5 millionAscentage Pharma revenue rose 29% year over year to US$ 44.5 million for the six months ended June 30, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL6yrd94:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IE00B3QW5Z07.USD","BCDF","BK4112","SG9999014039.USD","BK4585","BK1574","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","SG9999014013.SGD","SG9999014005.SGD","NDAQ","06855","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","LU0314104364.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660793944","title":"Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660793944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660793944?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:00","pubTimestamp":1787180400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nTUA4ML19T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06855","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170810384","title":"Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1170810384","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170810384?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150452,"startTime":"0","endTime":"0","summary":"Here are the key evening market developments investors need to know. NDRC Advances 'Six Networks' Infrastructure Plan On August 19, the National Development and Reform Commission (NDRC) held a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159646","03130","02827","BK1147","BK1574","09939","BK1515","399300","07233","03188","83130","BK1161","02846","159982","82846","83188","159938"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":5,"totalSize":285,"code":"91000000","status":"200"}]}}